PUMA BIOTECHNOLOGY INC shareholders Q2 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 289$1,0200.00%
NORTHERN TRUST CORP 69,595$245,6710.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 396,396$1,399,2770.00%
STATE STREET CORP 166,578$588,0200.00%
MILLENNIUM MANAGEMENT LLC 263,800$931,2140.00%
Tower Research Capital LLC (TRC) 35$1240.00%
GOLDMAN SACHS GROUP INC 73,914$260,9160.00%
MORGAN STANLEY 323,603$1,142,3190.00%
WOLVERINE TRADING, LLC 11,000$37,4000.00%
BlackRock Inc. 1,517,305$5,356,0870.00%
Bank of New York Mellon Corp 72,268$255,1060.00%
GHP Investment Advisors, Inc. 1,170$4,5280.00%
MACQUARIE GROUP LTD 61,255$216,0000.00%
Citadel Advisors 16,900$59,6570.00%
Citadel Advisors 11,000$38,8300.00%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q2 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.